Frontlight ResearchEarly access
CompletedNo phase
SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 10 Nov 2022
- Ended
- 9 Jul 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SmokefreeSGM
- SmokefreeTXT
- Record updated
- 17 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Self-identify as an LGBTQ+ individual
- Currently live in the United States
- Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day
- Are willing to quit smoking in the next 15 days
- Have a cell phone number with an unlimited short message service (SMS) plan
- Have a positive cotinine saliva test to indicate their smoking status
Who cannot take part
- Current use of tobacco cessation medications
- Contraindication for nicotine patches. Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure. Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease. Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches. If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study
- Have a prepaid cell phone plan (pay-as-you-go plan)
- Have a cell phone number that does not work and/or is registered to someone else
- Have inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-person
- Pregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)
- Enrollment in another smoking cessation study
- Non-English speakers
Where in United States
- The University of Texas Health Science Center at HoustonHouston, United States
About the trial
What the trial wants to find out
The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program
The 2 groups in the trial
- SmokefreeSGMTreatment being tested
- SmokefreeTXTExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 17 August 2025